Laurel Wealth Advisors (North Carolina)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $60K | Buy |
6,653
+6,593
| +10,988% | +$59.5K | ﹤0.01% | 541 |
|
2025
Q1 | $6.72K | Hold |
60
| – | – | ﹤0.01% | 513 |
|
2024
Q4 | $5.54K | Hold |
60
| – | – | ﹤0.01% | 540 |
|
2024
Q3 | $5.03K | Hold |
60
| – | – | ﹤0.01% | 515 |
|
2024
Q2 | $4.12K | Sell |
60
-15
| -20% | -$1.03K | ﹤0.01% | 498 |
|
2024
Q1 | $5.49K | Buy |
75
+15
| +25% | +$1.1K | ﹤0.01% | 478 |
|
2023
Q4 | $4.86K | Sell |
60
-10
| -14% | -$810 | ﹤0.01% | 457 |
|
2023
Q3 | $5.25K | Hold |
70
| – | – | ﹤0.01% | 444 |
|
2023
Q2 | $5.4K | Hold |
70
| – | – | ﹤0.01% | 447 |
|
2023
Q1 | $5.81K | Hold |
70
| – | – | ﹤0.01% | 444 |
|
2022
Q4 | $6.01K | Hold |
70
| – | – | ﹤0.01% | 412 |
|
2022
Q3 | $4K | Hold |
70
| – | – | ﹤0.01% | 434 |
|
2022
Q2 | $4K | Buy |
70
+10
| +17% | +$571 | ﹤0.01% | 463 |
|
2022
Q1 | $4K | Buy |
+60
| New | +$4K | ﹤0.01% | 499 |
|
2021
Q3 | – | Sell |
-45
| Closed | -$3K | – | 688 |
|
2021
Q2 | $3K | Buy |
+45
| New | +$3K | ﹤0.01% | 608 |
|
2021
Q1 | – | Sell |
-150
| Closed | -$9K | – | 667 |
|
2020
Q4 | $9K | Sell |
150
-175
| -54% | -$10.5K | ﹤0.01% | 421 |
|
2020
Q3 | $21K | Hold |
325
| – | – | 0.01% | 308 |
|
2020
Q2 | $25K | Buy |
325
+225
| +225% | +$17.3K | 0.01% | 289 |
|
2020
Q1 | $7K | Buy |
+100
| New | +$7K | ﹤0.01% | 387 |
|